Invicta Diagnostic's IPO debuted strongly on December 8, listing at ₹100, a 17.65% premium over its issue price of ₹85. The ...

Shares of Invicta Diagnostic listed at Rs 100 per share on the Emerge platform of the National Stock Exchange (NSE). The Rs 28.12 crore issue had a price band of Rs 80-85 per share.

Known as the Future Network Test Facility (FNTF), the large-scale, distributed AI-computing network links data centres spread ...

Invicta Diagnostic was trading at Rs 95 on the NSE, a 11.76% premium to the issue price of Rs 85. Invicta Diagnostic's IPO was subscribed 4.05 times. The issue opened for bidding on 1 December 2025 ...

New research shows that deep learning can use EEG signals to distinguish Alzheimer’s disease from frontotemporal dementia ...

Automotive Technology program is excited to announce an expansion of its course offerings this semester. With the addition of new faculty member Jeremy Kirtley, ...

Dementia is a group of disorders that gradually impair memory, thinking and daily functioning. Alzheimer's disease (AD), the ...

The assay detects aggressive prostate tumors in men on active surveillance for low-risk cancer, potentially helping them ...

NEXT reports that business insurance, like general liability and workers' compensation, can cover medical costs for injuries ...

Invicta Diagnostic is set to debut on the NSE SME platform on December 8, following a successful IPO that raised 28.12 crore.

Mayo Clinic Labs CEO explains how healthcare's data revolution reshapes clinical diagnostics and accelerates medical research.

FixBot can check on the health of your devices and talk you through necessary repairs. You can even point your phone's camera ...